Rheumatoid arthritis is a whole-body disease, not just a joint problem. While it starts with painful, swollen joints, the same immune-driven inflammation can damage the heart, lungs, eyes, blood cells, and even the spine. Understanding what’s happening beneath the surface helps explain why RA causes fatigue, shortness of breath, and other symptoms that seem unrelated to your joints.
What Happens Inside the Joints
Rheumatoid arthritis begins when the immune system mistakenly attacks the synovial membrane, the thin tissue lining the inside of your joints. Immune cells, including T cells, B cells, and specialized bone-destroying cells called osteoclasts, flood the joint and release a cascade of inflammatory signals. The most damaging of these are TNF-alpha, IL-6, and IL-1, molecules that act like alarm bells telling the body to keep sending reinforcements to a fight that doesn’t need to happen.
This chronic inflammation causes the synovial membrane to thicken dramatically, forming an aggressive tissue called pannus. Pannus is particularly destructive because it releases enzymes that actively break down cartilage and bone. Making things worse, the fibroblasts (structural cells) in this inflamed tissue resist the normal cell-death process that would usually keep them in check. They also produce signals that stimulate new blood vessel growth, feeding the pannus and creating a self-sustaining loop of inflammation and tissue destruction. Without treatment, this cycle erodes the joint surfaces, leading to the deformities and loss of function that characterize advanced RA.
Morning Stiffness and Daily Symptoms
The hallmark early symptom is morning stiffness lasting more than one hour, often stretching to several hours. This is a key distinction from osteoarthritis, where stiffness typically resolves within minutes. The duration of morning stiffness tracks closely with how active the inflammation is on any given day, so it serves as a built-in gauge of disease activity. Joints on both sides of the body are usually affected symmetrically: both wrists, both sets of knuckles, both knees.
Fatigue is nearly universal and often more disabling than the joint pain itself. It’s driven partly by the constant inflammatory signaling and partly by the anemia that develops in many people with RA (more on that below). Together, these symptoms create a daily reality where energy is limited and physical tasks that used to be automatic require conscious effort and planning.
How RA Affects the Lungs
The lungs are one of the most commonly affected organs outside the joints. A meta-analysis of global data found that roughly 21% of people with RA develop interstitial lung disease, a condition where inflammation and scarring damage the tissue between the air sacs. This makes the lungs stiffer and less efficient at transferring oxygen into the blood. The two most common patterns are usual interstitial pneumonia (about 11% of RA patients) and nonspecific interstitial pneumonia (about 7%).
Symptoms develop gradually. You might notice a dry cough that won’t go away or find yourself getting winded during activities that used to be easy. Because these changes creep in slowly, lung involvement often goes undetected until it’s moderately advanced. Some RA medications can also contribute to lung problems, which makes regular monitoring important for anyone with the disease.
Cardiovascular Risk
Heart disease is the leading cause of death in people with RA, and the risk is substantially higher than in the general population. The same inflammatory molecules circulating through the bloodstream don’t just target joints. They accelerate atherosclerosis, the buildup of fatty plaques inside artery walls. TNF-alpha and IL-6 damage the inner lining of blood vessels, making plaques more likely to form and more likely to rupture, which is what triggers heart attacks and strokes.
This elevated cardiovascular risk exists even after accounting for traditional risk factors like smoking, high cholesterol, and high blood pressure. People with RA who have well-controlled inflammation tend to have better cardiovascular outcomes, which is one reason rheumatologists push for aggressive early treatment rather than waiting to see how the disease progresses.
Anemia and Blood Cell Changes
Chronic inflammation takes a measurable toll on the blood. Studies estimate that roughly 60% of RA patients develop anemia, and about two-thirds of those cases are classified as anemia of chronic disease rather than iron deficiency. The mechanism is direct: TNF-alpha, the same inflammatory molecule destroying joint tissue, triggers premature death of young red blood cell precursors in the bone marrow. Higher TNF-alpha levels correlate with lower hemoglobin and fewer surviving blood cell progenitors.
This type of anemia doesn’t respond well to iron supplements because the problem isn’t a lack of iron. It’s that the bone marrow can’t produce red blood cells fast enough to replace the ones being lost to inflammation-driven cell death. The practical result is persistent fatigue, weakness, and pallor that improves only when the underlying inflammation is brought under control. Treatments that block TNF-alpha have been shown to reverse this process by allowing bone marrow cells to survive and mature normally.
Eye Inflammation
RA can affect the eyes in several ways. The most common problem is dry eye, occurring in about 28% of patients. This happens because the same immune attack that targets joint tissue can also damage the glands that produce tears.
Less common but more serious is episcleritis (inflammation of the tissue covering the white of the eye), which affects about 3% of RA patients. Scleritis, a deeper and more painful inflammation, occurs in roughly 1% to 6% of cases. Scleritis can cause significant eye pain, redness, and, if untreated, vision loss. It sometimes appears before joint symptoms do, or during a disease flare.
Skin: Rheumatoid Nodules
About 20% to 30% of people with RA develop rheumatoid nodules, firm lumps that form under the skin. They typically appear on pressure points like the elbows, forearms, backs of the hands, and the Achilles tendon area. Nodules are more common in people who test positive for rheumatoid factor, a blood marker linked to more aggressive disease. They’re usually painless unless they press on a nerve or form in an inconvenient location, but they can be cosmetically bothersome and sometimes signal that the disease is not well controlled.
Cervical Spine and Neurological Risk
One of the more serious but less discussed complications involves the upper neck. RA is the most common inflammatory disease affecting the cervical spine, and the joint most at risk is the atlantoaxial joint, where the top two vertebrae connect at the base of the skull. Chronic inflammation loosens the ligaments holding this joint in place, allowing the vertebrae to shift out of alignment. This is called atlantoaxial subluxation.
In severe cases, the bony projection of the second vertebra can migrate upward into the opening at the base of the skull and compress the brainstem. Early signs include neck pain, weakness in the hands and arms, and exaggerated reflexes. At its worst, this compression can cause difficulty walking, loss of coordination, and, in rare cases, acute respiratory failure. MRI imaging in affected patients has shown the brainstem being physically displaced by the shifted bone. This complication is most common in people with long-standing, poorly controlled disease and is one reason regular imaging of the neck is recommended for patients with advanced RA.
How RA Is Identified
Two blood tests help confirm a diagnosis. Rheumatoid factor (RF) is positive in about 75% to 80% of people with RA, but it can also show up in other conditions, limiting its precision. Anti-CCP antibodies are somewhat less sensitive (65% to 80%) but far more specific, with up to 98% accuracy for RA. A positive anti-CCP test in someone with joint symptoms is a strong indicator. People who test positive for both markers tend to have more aggressive disease and are at higher risk for the systemic complications described above.
Inflammatory markers like C-reactive protein and the erythrocyte sedimentation rate help track how active the disease is over time, though they don’t confirm RA on their own. Imaging, particularly ultrasound and MRI, can detect joint inflammation and early erosion before damage shows up on standard X-rays.